These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6976456)

  • 1. [Sequential study of immunopathological findings of skin in systemic lupus erythematosus (author's transl)].
    Kazama T; Tanaka Y; Ishibashi Y; Morikawa T; Suetsugu T; Sugisaki T; Shiwachi N; Ito S; Yonekura M; Sato S; Kitazawa K; Yamamoto J
    Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1073-86. PubMed ID: 6976456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical usefulness of the lupus band test].
    Benoldi D; Manganelli P; Scioscioli S
    G Ital Dermatol Venereol; 1987 Oct; 122(10):495-7. PubMed ID: 3327807
    [No Abstract]   [Full Text] [Related]  

  • 3. Semiologic value of C1q and C4 cutaneous deposits. An immunofluorescent study.
    Gomes MA; Fernandez-Bussy R; Ohrt C; Thivolet J
    J Cutan Pathol; 1982 Jun; 9(3):169-74. PubMed ID: 6752226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
    Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunopathology of the kidney in disseminated lupus erythematosus].
    Morel-Maroger L; Méry JP
    Pathol Biol (Paris); 1975 Jun; 23(6):492-3. PubMed ID: 1105354
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective complete Clq deficiency associated with systemic lupus erythematosus.
    Steinsson K; McLean RH; Merrow M; Rothfield NF; Weinstein A
    J Rheumatol; 1983 Aug; 10(4):590-4. PubMed ID: 6413687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lupus band test as a measure of disease activity in systemic lupus erythematosus.
    Halberg P; Ullman S; Jørgensen F
    Arch Dermatol; 1982 Aug; 118(8):572-6. PubMed ID: 7103527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of the lupus band test in systemic lupus erythematosus (author's transl)].
    Yasue T
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):901-7. PubMed ID: 7012400
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological studies in systemic lupus erythematosus.
    Jin OC; Jacob E; Chua D; Lan YS; Hsii FP
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():10-7. PubMed ID: 304878
    [No Abstract]   [Full Text] [Related]  

  • 14. Variability of the lupus band test. Results in 18 patients with systemic lupus erythematosus.
    Jacobs MI; Schned ES; Bystryn JC
    Arch Dermatol; 1983 Nov; 119(11):883-9. PubMed ID: 6357104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-obstructive nephrolithiasis: metabolic and immunopathological studies.
    Jeantet A; Tetta C; Camussi G; Ferrando U; Rotunno M; Thea A; Gaido M; Vercellone A
    Contrib Nephrol; 1985; 49():123-7. PubMed ID: 3913569
    [No Abstract]   [Full Text] [Related]  

  • 16. Mannose binding lectin deposition in skin of lupus erythematosus patients: a case series.
    Wallim LR; Nisihara R; Skare T; Mocelin V; Messias-Reason IJ
    Hum Immunol; 2014 Jul; 75(7):629-32. PubMed ID: 24798938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement system in disseminated lupus erythematosus].
    Vasquez JJ; Fontan G; Gil A; Barbado J; Alvarez I; Ojeda JA
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):725-31. PubMed ID: 76330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical analysis of the affected skin in patients with lupus erythematosus and its significance (author's transl)].
    Igarashi R
    Nihon Hifuka Gakkai Zasshi; 1979; 89(12):831-51. PubMed ID: 392146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of renal histological findings, serum C3, C4 level in patients with lupus nephritis by steroid therapy].
    Sueishi M; Tomioka H; Yanagisawa T; Nawata Y; Kagami M; Koike T; Takabayashi K; Yoshida S; Kumagai A; Tsuchida H
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):343-52. PubMed ID: 6471579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological parameters in subjects with essential arterial hypertension. II. Serological observations].
    Obbiassi M; Bigi G; Cancellieri V; Palmieri G; Morganti A; Tempesti P; Lettino M
    Boll Ist Sieroter Milan; 1982; 61(6):494-8. PubMed ID: 6985421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.